Clinical Trial

Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration

Recruiting
View on ClinicalTrials.gov →
Summary
This Long-term follow-up is designed to evaluate the safety of patient with Acute Myocardial Infarction who had administered Hearticellgram-AMI.
Trial Details
NCT Number NCT07400458
Lead Sponsor Pharmicell Co., Ltd.
Conditions Acute Myocardial Infarction
Enrollment 100 participants
Start Date 2022-03-03
Primary Completion 2028-10-12 (estimated)
Study Completion 2032-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-10